Browse Studies — Arctuva

Real-World Evidence Observational Study to Evaluate the Safety of iDose® TR (Travoprost Intracameral Implant) 75 µg in an Office-Based Surgery Setting

Clinical in-use observational trial to evaluate the administration of iDose TR (travoprost intracameral implant) in an office-based surgery setting.

Open Angle Glaucoma (OAG)Ocular Hypertension (OHT)

Estimated

~$10 – $1,050

Glaukos CorporationNCT07816692

Phase 1

A Phase 1/2 Study of REGN22530 in Participants With Primary Open Angle Glaucoma or Ocular Hypertension

This study will test an experimental drug called REGN22530 ("study drug") to see if it can help treat people with primary open angle glaucoma or ocular hyperte…

Primary Open Angle Glaucoma (POAG)Ocular Hypertension (OHT)

Estimated

~$10 – $8,750

Regeneron PharmaceuticalsNCT07675824

Phase 4

Multicenter, Randomized, Double-masked, Parallel Group Trial to Evaluate the Safety and Efficacy of iDose® TR (Travoprost Intracameral Implant) in Conjunction With Cataract Surgery vs. Cataract Surgery Alone

This trial will evaluate the safety and IOP -lowering efficacy of administering an iDose TR (travoprost intracameral implant) in conjunction with cataract surg…

Glaucoma, Open-angleOcular Hypertension (OHT)Phacoemulsification Cataract Surgery

Estimated

~$10 – $8,750

Glaukos CorporationNCT06848946

Observational

A Randomized Controlled Trial Comparing Direct Selective Laser Trabeculoplasty (DSLT) and Selective Laser Trabeculoplasty (SLT) in Reducing Intraocular Pressure in Open-Angle Glaucoma

This study compares two FDA-approved laser treatments for glaucoma: Direct Selective Laser Trabeculoplasty (DSLT) and Selective Laser Trabeculoplasty (SLT). Bo…

Open-angle Glaucoma (OAG)Ocular Hypertension (OHT)

Estimated

~$10 – $6,250

Medical University of South CarolinaNCT07408154